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Abstract
At least six histone H1 variants exist in somatic mammalian cells that bind to the linker DNA and stabilize the nucleosome
particle contributing to higher order chromatin compaction. In addition, H1 seems to be actively involved in the regulation
of gene expression. However, it is not well known whether the different variants have distinct roles or if they regulate
specific promoters. We have explored this by inducible shRNA-mediated knock-down of each of the H1 variants in a human
breast cancer cell line. Rapid inhibition of each H1 variant was not compensated for by changes of expression of other
variants. Microarray experiments have shown a different subset of genes to be altered in each H1 knock-down. Interestingly,
H1.2 depletion caused specific effects such as a cell cycle G1-phase arrest, the repressed expression of a number of cell cycle
genes, and decreased global nucleosome spacing. On its side, H1.4 depletion caused cell death in T47D cells, providing the
first evidence of the essential role of an H1 variant for survival in a human cell type. Thus, specific phenotypes are observed
in breast cancer cells depleted of individual histone H1 variants, supporting the theory that distinct roles exist for the linker
histone variants.
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Introduction
Eukaryotic DNA is packaged into chromatin through its
association with histone proteins. Chromatin is composed of
nucleosomes. The nucleosome core particle consists of 146 base
pair units wrapped around a histone octamer consisting of two
copies each of the core histone proteins H2A, H2B, H3 and H4.
The linker histone H1 sits at the base of the nucleosome near the
DNA entry and exit sites and is involved in the folding and
stabilization of the 30 nm chromatin fiber [1,2]. The amount of H1
per nucleosome is very variable, and the paradigm of one H1 per
nucleosome is more the exception than the rule [3]. Histone H1 is a
lysine-rich protein with a short basic N-terminal tail, a highly
conserved central globular domain and a long positively-charged C-
terminal tail. These tails are post-translationally modified, mostly by
phosphorylation, but also by acetylation and methylation [4,5].
CDK-dependent phosphorylation of H1 occurs progressively
throughout the cell cycle, with a maximum during mitosis [6].
Histone H1 in vertebrates is a family of closely related, single-
gene encoded proteins, showing much less evolutionary conserva-
tion than core histones. In mammals, five somatic subtypes (from
H1.1 to H1.5), a terminally differentiated expressed isoform
(H1.0), two tissue-specific variants (H1 testis and H1 oocyte) and a
recently described, poorly characterized H1x variant have been
identified [7–10].
Histone H1 participates in nucleosome positioning or spacing
and formation of the higher-order chromatin structure. H1-
containing chromatin is more resistant to nuclease digestion and
shows strong inhibition of nucleosome sliding [11]. Consequently,
H1 is seen as a structural component related to chromatin
compaction and inaccessibility to transcription factors or RNA
polymerase. Nonetheless, it has been suggested that histone H1
plays a more dynamic and gene-specific role, participating in
activation or repression of gene expression. Previous studies on the
effect of H1 depletion on global gene expression have reported
changes in the expression of small groups of genes, instead of it
affecting the vast majority of cellular genes [12–16]. Overexpres-
sion experiments have also contributed to challenge the concept of
H1 as a general repressor of chromatin activity. In Xenopus laevis
embryos, over-expression of the somatic H1 variant repressed
oocyte- but not somatic-type 5S rRNA genes or other Pol III
transcripts [17]. Overexpression of H1.0 and H1.2 isoforms
increase both the basal and hormone-induced levels of the mouse
mammary tumor virus (MMTV) reporter gene transcript [18].
Gene-specific effects of H1 might result from interactions with
specific regulatory factors or DNA-binding proteins. This might
also be the origin of reported specific functions for some H1
variants. H1.5 cooperates with the transcription factor MSX1 for
inhibition of specific target promoters and myogenesis [19]. H1.4
is involved in a heterochromatinization process. H1.4 at Lys26 is
deacetylated by SirT1 and subsequently methylated, facilitating
recruitment of Polycomb complexes and HP1, whereas simulta-
neous phosphorylation of Ser27 blocks HP1 binding [20–23].
Recently, a novel H1.2 complex acting as a repressor of p53-
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mediated transcription has been isolated [24]. In addition, H1.2
has been involved in apoptosis induced by DNA double-strand
breaks, acting as a cytochrome c-releasing factor that appears in
the cytoplasm after X-ray irradiation [25].
A strong decrease in histone H1 has drastic consequences on the
life span of some organisms [26–28]. However, single or double
H1 variant knock-out mice have no apparent phenotype due to
the compensatory up-regulation of other subtypes [29]. These
reports have favored the thinking that H1 variants are redundant,
lacking specific functions in chromatin organization or gene
expression control. Knocking out additional subtypes cannot be
compensated for fully by up-regulation of the remaining subtypes
[30]. Nonetheless, triple null H1.2-H1.3-H1.5 mouse embryonic
stem (ES) cells with a 50% global reduction in total H1 can be
obtained [12]. The electrostatic effect of this reduction is
apparently compensated for by a reduction in nucleosome repeat
length (NRL), in line with a previously reported strong linear
relationship between NRL and the H1/nucleosome ratio
(reviewed in [3]), together with other mechanisms such as changes
in core histone modifications. In this triple KO ES cell line, a very
limited number of genes change their expression. These include
imprinted genes regulated by DNA methylation, in which specific
CpG regions are downmethylated in the absence of H1 [12].
We have previously described a complex role of the linker
histone in the chromatin remodeling events taking place at the
MMTV promoter in response to progestin. In vitro, histone H1
enhances transactivation in the simultaneous presence of the
progesterone receptor (PR) and Nuclear Factor 1 (NF1). The first
step following initial binding of PR to the exposed HREs is
phosphorylation of histone H1. Then, PR recruits an ATP-
dependant chromatin remodeling complex, which changes the
structure of the nucleosomal core particles making its DNA more
accessible for NF1 and additional PR binding. In a last step, H1
leaves the promoter to enable efficient transcription initiation
[31,32]. In this work, no attempt was made to define the role of
individual H1 variants.
In order to further characterize in vivo the role of histone H1
variants and, in particular, to ascertain whether there is any
functional specificity, we developed an inducible shRNA express-
ing system for the depletion of individual H1 variants in the
human breast cancer cell line T47D. We achieved reliable specific
inhibition for each variant, avoiding compensation effects and
demonstrated significant differences among H1 variants, with
regard to cell cycle progression and gene expression. On the one
hand, depletion of H1.4 leads to cell death in T47D. This is the
first time that it has been noted that one variant is essential for
survival in a human cell type. On the other, we describe the
involvement of H1.2 in cell cycle progression. Its inhibition caused
a G1 arrest, defects in chromatin structure and changes in
expression of specific genes linked to cell cycle.
Materials and Methods
Cell Lines and Culturing Conditions
H1 knock-down cell lines were established from T47D-MTVL
cells (carrying one stably integrated copy of luciferase reporter
gene driven by the MMTV promoter; [33]. These cell lines were
grown in RPMI 1640 medium, supplemented with 10% FBS,
2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin. Doxycycline (Sigma) was added at 2.5 mg/ml when
indicated. Along a 6-day treatment with Dox, cells were passaged
at day 3. When indicated, serum-containing media was replaced
with serum-free media at day 4 for growth arrest. Images of H1
KD cell lines grown in normal conditions were taken using an
inverted Leica DMR microscope.
Other cell lines used were grown as follows: MCF-7 cell line was
grown at 37uC with 5% CO2 in MEM medium containing 10%
fetal bovine serum, 1% penicillin/streptomycin, 1% non-essential
amino acids, 1% sodium pyruvate and 1% glutamine. MCF10A
was grown at 37uC with 5% CO2 in F-12 MEM medium
containing 10% fetal bovine serum, 1% penicillin/streptomycin,
10 ml of insulin, 1028 M cholera toxin, 0.5 mg/ml of hydrocor-
tisone and 10 ng/ml of EGF. HEK 293T was grown at 37uC with
5% CO2 in Dulbecco’s modified Eagle medium (DMEM)
containing 10% fetal bovine serum, 1% glutamine and 1%
penicillin/streptomycin. HeLa was grown at 37uC with 5% CO2
in DMEM medium containing 10% fetal bovine serum and 1%
penicillin/streptomycin.
shRNA Cloning, Virus Production, and Cell Infections
Plasmids for the lentivirus vector-mediated drug-inducible RNA
interference system (pLVTHM, ptTR-KRAB-Red, pCMC-R8.91
and pMD.G) were provided by D. Trono (University of Geneva)
[34]. The 64-mer oligonucleotides for histone H1 shRNA cloning
into MluI/ClaI-digested pLVTHM were designed, annealed and
phosphorylated as communicated by D. Trono (http://tronolab.epfl.
ch/). Oligonucleotides have the following general structure: 59-
CGCGTCCCC-N19 TTCAAGAGA-rcN19-TTTTTGGAAAT-
39 and 59-AGGGG-N19-AAGTTCTCT-rcN19-AAAAACCTT-
TAGC-39, being N19 the specific target sequence for each H1 variant
and rcN19 its reverse complementary sequence. The corresponding
19-mer gene-specific target sequences for interference were designed
manually following standard rules (AAN19, GC % 30–70). Target
sequences (N19) are CGCTGACTCGCAGATCAAG for H1.0,
AGAGCGTAGCGGAGTTTCT for H1.2, CTGCCAAGAGTC-
CAGCTAA for H1.3, GAAGAGCGCCAAGAAGACC for H1.4
and GGCAACTAAGAAGGCTGCC for H1.5.
For the production of viral particles containing the HIV-derived
vectors, 2.56106 HEK 293T cells (Clontech) were transfected with
plasmids ptTR-KRAB-Red, pLVTHM-shH1.n or pEV833-HA-
H1.n (10 mg), pCMV-R8.91 (6.5 mg) and pMD.G (3.5 mg) in
10 cm dishes using calcium phosphate. Medium was collected
every 24 hours for 2 days and centrifuged 1h30min at 26,000 rpm
Author Summary
Eukaryotic DNA is packaged into chromatin through its
association with histone proteins. The linker histone H1 sits
at the base of the nucleosome near the DNA entry and exit
sites to stabilize two full turns of DNA. In particular, histone
H1 participates in nucleosome spacing and formation of
the higher-order chromatin structure. In addition, H1
seems to be actively involved in the regulation of gene
expression. Histone H1 in mammals is a family of closely
related, single-gene encoded proteins, including five
somatic subtypes (from H1.1 to H1.5) and a terminally
differentiated expressed isoform (H1.0). It is not well
known whether the different variants have distinct roles or
if they regulate specific promoters. We have explored this
by inducible knock-down of each of the H1 variants in
breast cancer cells. A different subset of genes is altered in
each H1 knock-down, and depletion has different effects
on cell survival. Interestingly, H1.2 and H1.4 depletion
specifically caused arrest of cell proliferation. Concomitant
with this, H1.2 depletion caused decreased global nucle-
osome spacing and repressed expression of a number of
cell cycle genes. Thus, specific phenotypes are observed in
breast cancer cells depleted of individual histone H1
variants.
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at 4uC in a sucrose gradient to concentrate viruses. Pellet
containing viral particles was dissolved in medium and used for
cell infection. Cells were infected using the spinoculation method,
i.e. plates were centrifuged at 1,2006 g for 2 h at 25uC.
Initially, a cell line expressing the Dox-responsive KRAB
repressor and RedFP (ptTR-KRAB-Red) was generated. Then,
this cell line was infected with viruses for expression of the different
H1 variants shRNAs (pLVTHM). The inducible knocked-down
cell lines were sorted in a FACSvantageSE (Becton Dickinson) for
RedFP-positive and GFP-positive fluorescence after 3 days of Dox
treatment. Then cells were amplified in the absence of Dox until
an experiment was performed.
Stable Expression of HA-Tagged H1 Variants
Human histone H1 variants were PCR-amplified from genomic
DNA and cloned into pCDNA4-HA vector provided by D.
Reinberg’s group (NYU Medical School). The complete H1-HA
cassette was cloned into the lentiviral expression vector pEV833
provided by E. Verdin (Gladstone Institutes) upstream an IRES-
GFP cassette. Virus production and infections with pEV833-
derived lentivirus were performed as described above. shRNA-
resistant H1.2 and H1.4 were created by site-directed mutagenesis
with QuikChange Mutagenesis Kit (Stratagene). The introduced
changes (in lower case: AGAaCGgtcCGGcGTTagT for H1.2,
and GAAatctGCgAAGAAGACC for H1.4) did not alter the
amino acidic sequence.
Production of H1 Variant Specific Antibodies
The N-terminal domain of human H1 variants H1.1 to H1.5 was
used to design peptides for production of subtype-specific antibodies
(Figure S1). Peptides were synthesized and conjugated to a carrier
protein, Keyhole Limpet Hemocyanin (KLH), in the Proteomics
Facility of the Pompeu Fabra University. Each of two rabbits was
injected with 200 mg of peptide for each H1 variant, at two weeks
intervals, for a total of 4 immunizations. Sera were collected and
analyzed a week after last immunization. Antibodies were purified
in a HiTrap Protein A HP column (Amersham Biosciences)
according to manufacturer instructions and some are available
through Abcam Ltd. (Cambridge, UK): H1.1 (ab17584), H1.3
(ab24174) and H1.5 (ab24175). A second generation of antibodies
(including H1.2 ab17677 and H1.5 ab18208) was produced in
collaboration with Abcam starting from two-branched peptides
26(specific peptide)-Lys-Cys as reported elsewhere [35].
Protein Extraction, Gel Electrophoresis, Immunoblotting,
and Other Antibody-Based Methods
Histone H1 was purified by 5% perchloric acid lysis for 1 hour at
4uC. Soluble acid proteins were precipitated with 30% trichlor-
oacetic acid over night at 4uC, washed twice with 0.5 ml of acetone
and reconstituted in water. Whole cell extracts were obtained lysing
cells in Tris-HCl (pH 7.4) 25 mM, EDTA 1 mM, EGTA 1 mM
and SDS 1% plus protease and phosphatase inhibitors. Protein
concentration was determined in both cases by Micro BCA protein
assay (Pierce). Lysates or purified proteins were subjected to 12%
SDS-PAGE, transferred to a nitrocellulose membrane, blocked with
5% non-fat milk for 1 hour, incubated with primary antibodies over
night at 4uC and secondary antibodies conjugated to peroxidase for
1 hour at room temperature. Bands were visualized by chemilumi-
niscence using ECL system (Amersham). Quantifications were
performed with Image Gauge (FujiFilm) software.
The anti H1.0 (ab11079), H1 phospho-T146 (ab3596), HA-tag
(ab9110) and CDC2 (ab18) antibodies were from Abcam; anti
tubulin was from Sigma; anti CDK2 (m2), CDK4 (c22), CCND1,
p27 (c19), p16 (h156) and p21 (c19) antibodies were from Santa
Cruz; phospho-Rb (Ser 608) was from Cell Signalling.
Immunofluorescence and chromatin immunoprecipitation
(ChIP) assays with the HA-tag antibody were performed as
described previously [36]. CDKs were immunoprecpitated from
total cell extracts and its kinase activity measured on Rb or H1
protein substrates as described elsewhere [37,38].
Recombinant human H1 subtypes were purchased from Alexis
Biochemicals (produced in E. coli bacteria), or provided by N.
Happel (University of Go¨ttingen) (produced in yeast). Recombi-
nant Rb fragment 792–925 was kindly provided by O. Bachs
(IDIBABS-UB).
Cell Cycle Analysis
Cells were washed with cold PBS 16, fixed in 70% ethanol and
stained with Analysis solution: 3% Ribonuclease A (Sigma)
10 mg/ml, 3% solution A (38 mM sodium citrate, 500 mg/ml
propidium iodide) in PBS 16. Samples were analyzed using a
FACS Calibur machine (Becton Dickinson), CellQuest analysis
software and ModFit program.
MNase Digestion
Pellet of cells growing in rich medium and treated or not for 6
days with Dox was dissolved in buffer A (10 mM Tris-HCl
pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.3 M sucrose and 0.2 mM
PMSF) plus 0.2% of NP40 and incubated for 10 min at 4uC.
Nuclei were obtained after centrifugation and digested with 2.5
units of Mnase (Worthington) per 4 million of nuclei for 25 min at
room temperature in buffer A plus 10 mM CaCl2. DNA was
purified through a Qiagen column and run on 1.2% agarose gel.
RNA Extraction and RT-qPCR
Total RNA was extracted using the RNAsy Kit (Qiagen). The
quality of the RNA was analyzed using the Agilent Bioanalyzer
2100 and the RNA 6000 LabChip Kit (Agilent) with the Eukaryote
Total RNA Nano Assay. cDNA was generated from 100 ng of RNA
using Superscript First Strand Synthesis System (Invitrogen). Gene
products were analyzed by qPCR using SYBR Green Mix (Roche)
and specific oligonucleotides in a Roche 480 Lightcycler. Each
value was corrected by human GAPDH and expressed as relative
units. Each experiment was performed in triplicate. Gene-specific
oligonucleotide sequences are available on request.
SuperArray RT-qPCR and Microarrays
The RT Profiler PCR Array (APHS-020) from SuperArray
Biosciences Corporation is a 96-well plate containing primers for
84 cell cycle related genes, plus 5 housekeeping genes and 3 RNA
and PCR quality controls. The system also includes an instrument-
specific master mix and an optimized first strand synthesis kit. First
strand synthesis and qPCR was performed following instructions
from manufacturer and run in a Roche 480 Lightcycler.
Procedures for microarray hybridization and data analysis are
described elsewhere [36,39] and detailed in the Text S1.
Microarray data is available at GEO with accession numbers
GSE11294 and GSE12299 (http://www.ncbi.nlm.nih.gov/geo/
index.cgi).
Results
Inducible RNA Interference-Mediated Depletion of
Histone H1 Variants in Human Breast Cancer Cells
In order to explore the specificity of the different H1 subtypes in
gene expression control in breast cancer cells, we generated T47D-
Specificity of H1 Variants
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derived stable cell lines with reduced expression of each of the H1
variants specifically (H1.0 to H1.5). H1.1 was left out as it is not
expressed in T47D cells (Figure S1). We used an inducible shRNA
expression system based on a TeT-On strategy [34]. shRNAs
targeting divergent gene regions were designed to specifically
inhibit the H1.0, H1.2, H1.3, H1.4 and H1.5 variants of the linker
histone and cloned in the lentivirus vector pLVTHM. Knocked-
down cell lines were generated first by infecting the regulator
vector that expresses a RedFP marker and a repressor TetR-
KRAB fusion protein, then the vector codifying for the shRNA
and reporter GFP. Upon doxycycline (Dox) addition, derepression
of GFP and shRNA occurs and the targeted gene is knocked down.
Cells simultaneously expressing RedFP and GFP upon Dox
addition were selected by cell sorting. A control cell line was
generated by infection with the empty pLVTHM vector.
Depletion of the different H1 variants was analyzed by Western
blot with specific antibodies (See Materials and Methods and
Figure S1). H1.4 was detected with a H1 phospho-T146 antibody
characterized in Figure S1. Western blot analysis of H1-extracted
sample from each knocked-down cell line revealed a consistent and
specific reduction of every H1 variant (Figure 1A). No significant
compensation effects by other H1 subtypes were observed at
protein level, but a H1.0 increase after H1.4 depletion. Efficient
depletion was achieved after six days of treatment with Dox
(Figure 1B). Relative quantification of H1.2 inhibition by Western
blot showed a 8-fold decrease in protein level (Figure 1C).
Depletion of other isoforms oscillated between 70 and 99%
(Figure 1A). Electrospray mass spectrometry of H1 preparations
from all Dox-treated cell lines also showed specific reduction of
each H1 subtype identified by its differential molecular weight
(data not shown).
The knock-down effect was also measured by reverse transcrip-
tion and real-time PCR (RT-qPCR) analysis of H1 variants gene
expression before and after Dox treatment for all the cell lines
generated (Figure 1D). This showed specific reduction of the
targeted gene (between 60% and 90% depending on the variant)
and some increase in H1.0 mRNA in both H1.2 and H1.4
knocked-down cell lines. Significant reduction of H1 variants
transcripts due to shRNA expression occurred 2 days after Dox
addition (Figure 1E), earlier than the apparent reduction of H1
proteins.
Effect of H1 Variants Depletion on Cell Proliferation and
Cell Cycle Progression
Upon Dox treatment, we observed differences in growth rate
among H1 variant knock-downs, in particular, H1.2 and H1.4
depleted cells failed to reach confluency (Figure 2A) and exhibited a
slower growth rate. To quantify this we mixed, at a 1:1 ratio, each of
the shRNA expressing cell lines (RedFP and GFP-positive upon Dox
treatment) with parental T47D cells (RedFP and GFP-negative), and
we monitored by FACS the proportion between the two populations
over time in culture in the presence of Dox (Figure 2B). Slow
progression of H1.4 knocked-down cells was seen at six days after
Dox addition and of H1.2 depleted cells at day 9. At day 12, H1.5
depleted cells were also less abundant than the parental ones. In
addition, at day 6, H1.4 cells had changed morphology towards a
necrotic phenotype (Figure 2A and Figure S2).
To understand the causes of these proliferation defects, the cell
cycle profile of the different cell lines was examined by FACS
analysis of propidium iodide-stained cells six days after Dox
addition and compared to untreated cells. The knocked-down cell
lines for H1.0 and H1.3 did not show any significant difference in
the cell cycle profile in comparison to uninduced cells or to the
control cell line. On the other hand, both H1.2 and H1.4 depleted
cells exhibited a dramatic reduction in the S phase cell population
(Figure 2C and Table S1). H1.5 depletion caused a slight decrease
of S phase. Interestingly, in the H1.2 knock-down, an increase in
the G1 peak over controls and a concomitant decrease in G2 peak
were observed. That is, depletion of H1.2 induced G1 arrest. We
cannot discard that complete depletion of H1.0, H1.3 or H1.5
could have different effects.
H1.4 Is Required for Survival of T47D Cells
In the H1.4 knock-down, a small increase of G2 and almost no
change in G1 was observed. Although the cell cycle pattern was
not very dramatic, the increase in the subG1 peak indicates a high
level of mortality in the H1.4 depleted cells (Figure 2D), in
accordance with the cell growth experiments. Experiments
performed to measure apoptotic cells (such as formation of
apoptotic DNA ladder, anexin V binding or TUNEL assays) have
failed to find differences between H1.4-depleted and control cells,
indicating that cell death is not mediated by apoptosis (data not
shown). Based on these results, we conclude that H1.4 knocked-
down cells show a cell death phenotype, probably by necrosis,
although more accurate analysis needs to be done. The deleterious
effect of H1.4 depletion in T47D cells was rescued by transient
transfection of a plasmid expressing recombinant shRNA-resistant
H1.4 (Figure S2), discarding off-target effects.
H1.2 Depletion Causes Cell Cycle Arrest in G1
To further characterize the G1 arrest phenotype of H1.2-
depleted cells, we studied the cell cycle progression after recovering
from a serum-starvation block in G1. H1.2 knock-down (KD) cells
treated or not with Dox for 6 days were serum-starved for the last
two days. After serum addition, the cell cycle profile was determined
at 24, 30 and 48 h (Figure 2E and Table S1). Dox untreated cells
progressed along the cycle, with a maximum of cells in S phase at
24 h, in G2/M at 30 h, and in G1 at 48 h. Dox-treated cells
remained arrested in G1-phase, with little increase in cells in S-
phase at 30 h after serum addition. This indicated that the G1 block
caused by H1.2 depletion is strong and very few cells are able to
escape and progress through the cell cycle.
Hydroxyurea (HU) and methyl methanosulfonate (MMS) are
damaging agents that block cycling cells in S and S/G2 phase,
respectively. We investigated how these drugs affect the cell cycle
profile of 6Dox-treated H1.2 and H1.4 KD cells. While the cell
cycle profile of H1.4 KD in response to HU or MMS was
practically indistinguishable in the presence or absence of Dox
(data not shown), H1.2 KD cells treated with Dox remained
accumulated in G1 whether or not HU or MMS was present
(Figure 2F). Taken together, our results indicated that H1.2
depletion causes a strong G1 arrest phenotype and that H1.4 KD
cell cycle is not greatly affected in the few surviving cells.
G1 Arrest in H1.2 Depleted Cells Is Reverted Specifically
by Expression of the Targeted Protein
In order to demonstrate that the cell cycle arrest was specifically
due to the depletion of the H1.2 variant, we stably integrated into
the H1.2 KD cell line a lentiviral vector for the expression of an
shRNA-resistant H1.2-encoding gene C-terminally fused to the
HA peptide (rH1.2-HA). The levels of rH1.2-HA protein were
similar to the endogenous histone variant as shown by Western
blot analysis (Figure 3A). Cell cycle analysis demonstrated that the
G1 arrest observed in the H1.2 depleted cells was reversed when
the rH1.2-HA protein was present (Figure 3B).
Moreover, to exclude that the phenotype was not due to a
reduction in the total H1 content, we performed the experiment
Specificity of H1 Variants
PLoS Genetics | www.plosgenetics.org 4 October 2008 | Volume 4 | Issue 10 | e1000227
Figure 1. Inducible RNA interference-mediated knock-down of histone H1 variants in human breast cancer cells. T47D derivative cells
stably infected with the lentiviral inducible system for the expression of shRNAs against each of the human histone H1 variants indicated were
treated for 6 days with Dox or left untreated. (A) H1 depletion was tested by Western blot with isoform-specific antibodies on histone H1
preparations obtained by acid extraction. H1 phospho-T146 antibody was used to detect H1.4 (see Figure S1 for a characterization). The percentage
of specific H1 isoform depletion upon quantification by band densitometry is shown underneath. (B) Optimal histone H1 depletion is achieved after 6
days of Dox treatment. Western blot analysis of H1.2 depletion in a Dox treatment time-curve. (C) Relative quantification of H1.2 depletion upon Dox
treatment. Serial dilutions of the H1 sample extracted from non-treated cells were compared to a Dox-treated sample in a Western blot using anti
H1.2 antibody. This comparison shows that H1.2 was reduced 8-fold. (D) Inhibition of H1 expression was tested by RT followed by real-time PCR
(qPCR) with oligonucleotides specific for the different human H1 variant genes. Data is expressed as fold change (FC) of H1 gene expression corrected
by GAPDH in response to Dox compared to untreated. The values represent the mean and SD of a representative experiment performed in triplicate.
(E) The effect of H1 shRNAs is seen earlier when expression of the H1 mRNA is followed by RT-PCR. This example shows H1.2 mRNA reduction along a
Dox time-course.
doi:10.1371/journal.pgen.1000227.g001
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Figure 2. Inhibition of H1 variants causes different effects on cell proliferation and cell cycle progression. (A) T47D cells infected with
the inducible shRNA-expression system against H1.2, H1.4 or empty plasmid were treated for 6 days with Dox or left untreated and observed at the
optical microscopy. (B) In order to measure the effect of H1 depletion on cell proliferation, each H1 variant knock-down cell line (RFP and GFP-
positive) was mixed 1:1 with parental T47D cells (RFP and GFP-negative) and treated with Dox. Every three days, cells were split and the percentage of
RFP/GFP-positive cells measured by FACS. Data is expressed as ratio of RFP/GFP-positive (KD) versus RFP/GFP-negative (wild-type) cells along time.
Data corresponds to a representative experiment performed in duplicate. (C) Cell cycle profile after propidium iodide (PI) staining of H1 variant knock-
down cell lines grown for six days in the presence or absence of Dox. Data is expressed as percentage of cells in G1, S and G2/M cell cycle phases. The
values represent the mean and SD of a representative experiment performed in triplicate. (D) H1.4 knocked-down and control cells grown in the
presence of Dox for 6 and 10 days were analyzed by FACS after PI staining to measure the percentage of cells in subG1phase as indicative of cell
Specificity of H1 Variants
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stably expressing ectopically each of the other HA-tagged H1
variants in the inducible H1.2 KD cell line. Incorporation of
recombinant HA-tagged H1 variants into chromatin was tested by
several means, including Western blot of H1 extracted from
chromatin, immunofluorescence and chromatin immunoprecipi-
tation (Figure S3). Expression of H1.4-HA and H1.5-HA was
comparable to rH1.2-HA, H1.0-HA level was sensibly lower, and
H1.3-HA approximately 10-fold inferior (Figure 3A). As Figure 3C
shows, none of the other variants was able to reverse the G1 arrest
caused by the depletion of H1.2. Taken together, this indicates
that H1.2 variant is specifically required for normal cell cycle
progression and its depletion causes cells to accumulate in G1
phase. Complementation results with H1.3-HA and, probably,
H1.0-HA are not definitive due to its lower expression levels.
Variant-Specific Effects of H1 Depletion in Cell
Progression Are Not Restricted to T47D Cells
In order to investigate whether the effect of H1.2 and H1.4
deletion on cell proliferation was specific to the breast cancer cell
line T47D used or if it is a more extended phenotype, we
introduced the inducible shRNA expression system in a different
breast adenocarcinoma cell line (MCF7), a non-tumoral breast
epithelial cell line (MCF10A), a cervical adenocarcinoma cell line
(HeLa) and an embryonic kidney cell line (293T). Efficient H1.2
and H1.4 depletion in response to Dox treatment was obtained for
all cell lines, ranging from 63 to 95% (Figure 4A and 4B). In vivo
observation of cells by microscope after 6 days of Dox treatment
indicated that H1.2 depletion caused a clear defect in MCF7 cell
growth, but not on HeLa, 293T or MCF10A (Figure 4C).
Interestingly, H1.2 depletion was more pronounced in MCF10A
than in MCF-7.
In order to better describe the cell proliferation defect, H1.2 KD
cells were cocultured 1:1 with parental cells, treated with Dox and
growth of the two populations was monitored by FACS along time
(Figure 4D). Growth of MCF7 H1.2 KD, but not MCF7 control or
MCF10A H1.2 KD, was slower than parental cells, and
comparable to the results shown for T47D H1.2 KD shown in
Figure 2B. Consequently, the effect of H1.2 depletion on cell
proliferation was not restricted to T47D, but observed also in a
different breast cancer cell line, MCF7. However, analysis of the
Figure 3. G1 arrest in H1.2 depleted cells is reverted specifically by expression of the targeted protein. (A) Expression of HA-tagged H1
variants in H1.2 knocked-down cells. shRNA-resistant H1.2 and the rest of H1 variants, fused to HA peptide at their C-termini, were introduced by
lentiviral infection into shH1.2 cells. Expression was measured with an anti-HA or H1 variant-specific antibodies by Western blot. Cells were treated
with Dox for 6 days when indicated. Coomassie staining of H1 preparations is shown as a loading standard. The degree of expression of each HA-
tagged variant in comparison to rH1.2-HA (100%) is shown. H1.3-HA could not be quantified precisely. (B) G1 arrest in H1.2 knocked-down cells is
reverted by stable expression of recombinant HA-tagged, shRNA-resistant H1.2, (C) but not by expression of other H1 variants. The values represent
the mean and SD of the percentage of cells in each of the cell cycle phases in H1.2 KD cells stably expressing the different H1 recombinant variants,
treated or not with Dox for 6 days. Representative experiments performed in triplicate are shown.
doi:10.1371/journal.pgen.1000227.g003
death. (E) H1.2 KD cells grown for six days in the presence or absence of Dox and without serum for the last two days, were treated with serum and
the cell cycle profile was analyzed at time points indicated. (F) Cell cycle profile of H1.2 KD cells in response to treatment with different inhibitors.
Cells were treated or not with Dox for 6 days. Hydroxyurea (HU) or methyl methanosulfonate (MMS) were added at the indicated concentrations 12 h
before analysis of the cell cycle profile by FACS measurement of PI-stained cells.
doi:10.1371/journal.pgen.1000227.g002
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Figure 4. Variant-specific effects of H1 depletion in cell progression are not restricted to T47D cells. HeLa, 293T, MCF7 and MCF10A cells
were infected with the inducible shRNA-expression system to inhibit expression of (A) H1.2 or (B) H1.4, and the efficacy of linker histone depletion
was tested in Western blot with specific antibodies. 293T cells infected with the empty shRNA-expression vector are shown as control. The
percentage of H1.2 (A) or H1.4 (B) depletion upon quantification by band densitometry is shown underneath. Coomassie staining of H1 preparation is
shown for each H1.2 KD cell line, were depletion of the lower band corresponding to H1.2 in response to Dox can be observed. (C) Cell lines indicated
infected with the inducible shRNA-expression system against H1.2 or H1.4 were treated for 6 days with Dox or left untreated and observed at the
optical microscopy for the number and morphology of attached cells. (D) The effect of H1.2 or H1.4 depletion on MCF7 and MCF10A cell proliferation
was measured by following by FACS the variation of the proportion between shRNA-infected (GFP-positive) and parental cells (GFP-negative) from
the 1:1 seeding ratio over indicated days in the presence of Dox as in Figure 2B. (E) H1.2 knocked-down cells grown in the presence of Dox for 6 days
were analyzed by FACS after PI staining to measure the percentage of cells in subG1phase as indicative of cell death.
doi:10.1371/journal.pgen.1000227.g004
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cell cycle profile has failed to show G1 arrest. Instead a clear
increase in the subG1 peak was observed in MCF7 cells
(Figure 4E). It is worth noting that, unlike T47D, the MCF7 cell
line is p53-positive and, consequently, prone to apoptotic death in
response to adverse stimuli. This could explain the differences
between the two breast cancer cell lines in response to H1.2
depletion.
On the other hand, H1.4 depletion was also obtained in the four
cell lines tested, but only in MCF10A did it affect cell proliferation,
as occurred in T47D (Figure 4B, 4C and 4D). Noteworthy, H1.4
depletion was stronger in HeLa cells, but no effect on cell
proliferation was observed. We cannot rule out that higher
depletion efficiencies (e.g. in MCF7 H1.4 KD) would produce
further effects. Nonetheless, our results strongly suggest that H1.2
and H1.4 are involved in processes related to normal cell cycle
progression in a cell type-dependent fashion.
H1.2 Knock-Down Causes a Reduction in Nucleosome
Spacing
Reduced H1 content (down to 50%) in triple-H1 null mouse
embryonic stem (ES) cells leads to reduced nucleosome spacing
(nucleosome repeat length), as measured after micrococcal
nuclease (MNase) digestion of nuclear bulk chromatin [12]. We
investigated nucleosome spacing of chromatin from the different
H1 variant T47D knock-downs by MNase digestion of isolated
nuclei (Figure 5A). H1.2 depletion, but not depletion of other H1
variants, caused a striking reduction in the spacing between
nucleosomes. The calculated nucleosome repeat length (NRL) was
decreased from approximately 184.7 to 173.5 upon H1.2
depletion (Figure 5B, obtained from five independent experi-
ments). This was surprising as H1.2 only represents approximately
23% of the total H1 content in T47D cells (Figure S1). As H1.2
depletion reached 90–95% and compensatory increases in the
expression of other H1 variants were not detected, we estimate
that total H1 content was reduced by approximately 20%. This
was confirmed by Coomassie staining of H1 preparations from
H1.2 KD cells treated or not with Dox (Figure S1). Stable
expression of HA-tagged, shRNA-resistant H1.2 in the H1.2 KD
cell line reverted the reduction in nucleosome spacing caused by
endogenous H1.2 depletion (Figure 5C).
In triple-H1 null ES cells, nucleosome spacing reduction was
accompanied by global changes in different histone post-
translational modifications [12]. Histone modifications, such as
trimethylation of K27 or trimethylation of K9 in core histone H3,
remain unchanged in our H1.2 depleted cells (data not shown).
Reduced H1.2 Content Leads Mostly to Repression of a
Limited Number of Genes
H1.2 depletion alters global chromatin structure as seen by the
reduction in nucleosome spacing. This could have some effect on
nuclear processes such as DNA replication or gene expression and,
ultimately, cell proliferation. We studied the effect of H1.2 depletion
on global gene expression. For this, we used a custom-made breast
cancer microarray platform containing 826 cDNA clones (see Text
S1) to compare H1.2 KD cell line treated for 6 days with Dox with
untreated cells and with control cells 6Dox. In order to avoid
comparing cells arrested in the cell cycle (H1.2 KD +Dox) with cells
normally cycling (H1.2 KD2Dox), all cells were equally arrested in
G1 by serum deprivation over the last two days of6Dox treatment
prior to RNA extraction (Figure 2E). Depletion of H1.2 caused an
alteration in the expression of a limited number of genes. Most of
altered genes were repressed in the absence of the histone: 11 genes
were up-regulated and 59 genes were down-regulated with a fold-
change higher than 1.4 (q#0.1), with the H1.2-encoding gene
(hist1h1c) being the strongest down-regulated cDNA due to the
shRNA specific action (Figure 6). These changes were not observed
in control cells, discarding an effect of Dox on gene expression. This
indicates that H1.2, rather than being a general repressor, is acting
direct or indirectly as positive regulator of gene expression. Among
the repressed genes, many of them are involved in cell cycle control.
Gene ontology identified 20 out of the 59 repressed genes as being
related to cell cycle, and 10 to cell division. This proportion is higher
than would be expected, considering the abundance of these gene
categories in the customized array. Alteration in the expression of
one or a subset of cell cycle genes could cause the G1 arrest.
Depletion of the Different H1 Variants Leads to Specific
Changes in Global Gene Expression
The analysis of the consequences of H1 depletion on global
gene expression was extended to the other H1 variants using
genome-wide Illumina microarrays containing more than 22,000
probes (see Text S1). All KD cell lines were treated or not with
Dox for 6 days, in duplicate, and arrested in G1 by 48 h of serum-
starvation prior to RNA extraction. A summary of the number of
genes up- or down-regulated with a fold-change $1.4 (false
discovery rate q#0.1) in each H1 variant KD cell line upon Dox
treatment in comparison to untreated cells is presented in Figure 7
and Tables S2 and S3.
The proportion of altered genes, up- or down-regulated, ranged
between 1 and 2-%, depending on the H1 variant under study.
Globally, approximately 6% of the genes are altered by depletion of
some of the variants. H1 depletion caused 1.5 times more down-
than up-regulation of genes. In particular, the ratio down- to up-
regulated ranged between 1 for H1.5 and 2.7 for H1.2. As reported
above, H1.2 depletion mostly leads to gene down-regulation.
A total of 533 genes were up-regulated by depletion of some H1
variant. Of these, 443 (83%) were unique to a single variant.
Seventy genes were up-regulated by two H1 variants, and 20 by
three or four variants. The number of genes down-regulated by
depletion of some variant was 812. Of these, 615 (76%) were
uniquely regulated, 111 genes were regulated by two variants, and
86 by more than two variants. Interestingly, H1.2, H1.3 and H1.4
were the variants that produced a higher proportion of uniquely-
regulated genes, indicating that these are the variants with a more
specific role in gene expression control. On the other hand, the
majority of genes down-regulated in H1.0 and H1.5 KD were also
affected by depletion of other H1 variants.
In conclusion, depletion of the different H1 variants caused an
alteration in the expression of a limited number of genes, different
in each H1 variant KD. Most of the genes are affected by a single
H1 variant, supporting the theory that H1 isoforms play specific
roles in gene expression. Nonetheless, a proportion of genes are
altered by more than one H1 variant, suggesting that redundant
roles for H1 variants may also exist.
Expression of Cell Cycle-Related Genes Is Altered in H1.2-
Depleted Cells
To further explore the relationship between H1.2 depletion and
the cell cycle gene expression profile, we tested expression of 84
cell cycle-related genes by RT-real time PCR using the Super-
Array (Bioscience Corporation) platform (Figure 8). Fourteen
genes were significantly repressed (more than 2-fold) when H1.2
was depleted after Dox addition for 6 days in serum-starved cells
(q#0.5). This number was increased to 24 repressed genes when
considering $1.5-fold and q#0.1, and included 10 genes already
identified in the customized microarray experiments: BIRC5,
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CDKN3, CDC20, CCNB2, CDC2, CCNB1, MAD2L1, CKS2, BCL2
and RBBP8. Among the newly identified genes were CDK2, PCNA,
MCM2, MCM3, MCM5, CDKN2A (p16INK4A) and CDKN2B
(p15INK4B). Only two genes were activated $2-fold: RBL2 and
CCNG2. In the same experiment, cells kept 6Dox (6 days) and
serum-starved (last two days) were further incubated with 10%
serum for an additional 12 hours period and RNA was extracted.
Differences in expression of the repressed genes were even higher,
confirming that expression of this subset of genes was affected as a
consequence of H1.2 depletion (Figure 8).
Expression of some of the identified genes was further analyzed
by conventional RT-qPCR with specific oligonucleotides. Inter-
estingly, we detected induction of the cell cycle inhibitor CDKN1A
(p21Cip1), which had not been observed using the previous
methods. Some of the genes were repressed (CDC2, CDKN3,
RFC3) or activated (CDKN1A) as early as 2 days after Dox addition.
Other genes were not repressed until day 6 (CDC20) (Figure S4).
Next, we tested whether inhibition of genes in H1.2 depleted cells
could be reverted by stable reintroduction of recombinant H1.2
(Figure 9A). Inhibition of CDC2, CCNB2, CDC20, MAD2L1 and
RFC3 was reverted by restoring H1.2 levels. Induction of CDKN1A
(p21Cip1) was only partially reverted by reintroduction of H1.2.
Expression of cell cycle-related genes may vary during cycle
progression. We investigated the effect of H1.2 depletion on the
expression of these genes over time after release from a serum-
starvation induced G1-arrest block. In H1.2-depleted cells (Dox-
treated), the response of the genes to serum was, in most of the
cases, delayed and reduced (Figure S4).
In order to test whether repression of this cell cycle gene subset
was specific to H1.2 depletion, we tested gene expression in
Figure 5. H1.2 knock-down causes a reduction in nucleosome spacing. (A) Nuclei from H1 variant knock-down cells treated or not with Dox
for 6 days were treated with MNase and the profile of bulk chromatin was analyzed in gel electrophoresis to calculate the nucleosome repeat length
(NRL). (B) Plot of nucleosome number versus DNA length for MNase-digested bulk chromatin of H1.2 knocked-down cells 6Dox. This plot has been
used to calculate the corresponding NRL. Data from 5 independent experiments has been pooled. Average6SD is shown. Data from untreated and
treated samples differed significantly in a t-Student test (95% confidence interval with a p value of 0.0001). Open triangles denote untreated, and
solid square symbols correspond to cells treated for 6 days with Dox. (C) Complementation of reduced nucleosome spacing in H1.2 knocked-down
cells by stable expression of shRNA-resistant H1.2 (rH1.2HA).
doi:10.1371/journal.pgen.1000227.g005
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control, H1.0, H1.2 and H1.4 knock-down cells6Dox, in parallel,
with the SuperArray platform (Table S4). Twenty-seven genes
were repressed ($1.5-fold) in comparison to control cells 6Dox
when H1.4 was depleted, with approximately 50% coincidence
with genes repressed upon H1.2 inhibition. This included CDKN3,
MAD2L1 and CCNB2. Only one gene was slightly activated. On
the other hand, H1.0 depletion caused activation of approximately
20 genes ($1.5-fold) and repression of only 2 genes. Our results
indicate that depletion of different H1 variants affect expression of
cell cycle-related genes diversely.
Cell Cycle Protein Profile in H1.2-Depleted Cells
In order to better characterize the G1 arrest caused by H1.2
depletion, we analyzed accumulation or phosphorylation of several
cell cycle regulators in 6Dox-treated H1.2 KD and control cells
by Western blot with specific antibodies (Figure 9B). Phosphorya-
tion of retinoblastoma protein (Rb) is a key gatekeeper of G1 to S
transition through the restriction point of the cell cycle [40,41]. Rb
phosphorylation was highly reduced in Dox-treated H1.2 KD
cells, but not in control cells, as shown in two different
experiments. Higher phoRb in H1.2 KD (2Dox) compared to
parental T47D observed in experiment 1 was not reproducible.
Rb phosphorylation is required for transcription of S-phase genes,
e.g. CDC2, PCNA and cyclins E/A. Some of them are consistently
down-regulated in H1.2 KD, such as CDC2 and PCNA.
Accordingly, the level of CDC2 protein was reduced in H1.2
KD cells +Dox (Figure 9B).
Figure 6. Genes with altered expression in H1.2 knock-down
cells. Genes indicated have increased or decreased expression $1.4-
fold in the presence of Dox versus in the absence of Dox (6 days)a. **,
q#0.05; *, 0.05#q#0.1; ns, non-significant. Gene onthologyb: cell cycle-
related genes are identified with CC. The nomenclature of genes is
shown in Table S5.
doi:10.1371/journal.pgen.1000227.g006
Figure 7. Summary of analysis of gene expression in H1 variant
KD cells with genome-wide microarrays. 1 Number of genes with
increased or decreased expression $1.4 fold (q#0.1) in the presence of
Dox versus in the absence of Dox (6 days). 2 Number of genes altered by
depletion of a particular isoform only. 3 Total refers to the genes altered
by depletion of some of the H1 isoforms. Genes affected by more than
one isoform are counted only once.
doi:10.1371/journal.pgen.1000227.g007
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Rb is consecutively phosphorylated in the G1 phase by the
CDK4/6-Cyclin D1 and CDK2-Cyclin E pairs. We did not detect
changes in the accumulation of Cyclin D1 or CDK4 proteins
(Figure 9B). Instead, CDK2 levels were reduced in H1.2 KD, as
well as the CDK2 -associated kinase activity immunoprecipitated
from these cells (Figure 9B and 9C). CDK2 gene expression was
also reduced upon H1.2 depletion (Figure 8 and Table S4). As
with CDC2, CDK2 down-regulation in H1.2 KD cells could also
help to explain the G1 arrest.
In the DNA damage response, p53-dependent induction of
expression of the CDK inhibitor p21Cip1 is involved in the defect
in Rb phosphorylation [42]. In our experiment, the levels of the
CDK inhibitors p21Cip1 and p27Kip1 did not change (Figure 9B),
although CDKN1A gene expression was increased in H1.2-depleted
cells (Figure 9A). Considering that T47D cells are p53-defective,
we cannot rule out that a different player affected ultimately by
H1.2 depletion, such as inhibitors of the INK4 family, is impacting
on Rb phosphorylation. One of these inhibitors, p16INK4A was not
detected in our cells (Figure 9B). We can conclude that G1 arrest
in H1.2 KD cells is caused by deregulation of cell cycle factors
upstream the phosphorylation of Rb, but its exact causes still
remain elusive to us as does, more importantly, the way in which
H1.2 governs regulation of these factors.
Discussion
Histone H1 is a structural component of chromatin related to
compaction and inaccessibility to transcription factors or RNA
polymerase. Nonetheless, it has been suggested that histone H1
plays a more dynamic and gene-specific role, participating in
Figure 8. Cell cycle-related genes with altered expression in H1.2 knock-down cells. Genes indicated have increased or decreased
expression $1.5-fold in the presence of Dox versus in the absence of Dox (6 days)a. **, q#0.05; *, 0.05#q#0.1. The nomenclature of genes is shown
in Table S6.
doi:10.1371/journal.pgen.1000227.g008
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activation or repression of gene expression. Moreover, it is not
fully understood to what extent H1 subtypes are functionally
redundant or exert specific functions. Previous reports indicate
that distinct H1 variants may have different properties and
implications for gene expression [8,18,43,44]. Our analysis by
means of inducible RNA interference allows for investigation of
the phenotypic and gene expression effects of variant-specific H1
depletion on a human breast cancer cell line, avoiding compen-
satory up-regulation of other H1 subtypes or epigenetic adaptation
to chromatin structure changes. We have confirmed that depletion
of H1 subtypes alters expression of different subsets of genes.
Particularly, we found that depletion of H1.2 leads mainly to
down-regulation of genes, supporting a positive role for this H1
variant in gene expression, rather than a general repressive role.
H1 Depletion Impacts on Cell Cycle Progression in a Cell
Type and H1 Variant-Specific Manner
We have investigated the consequences of sudden depletion of a
particular H1 subtype. We found that H1.2 and H1.4 have an
essential role in normal growth of a human breast cancer cell line
in culture. On the other hand, 70–90% depletion of H1.0, H1.3 or
H1.5 subtypes was compatible with normal cell growth. We
cannot discard that further depletion of these isoforms could have
additional consequences. To our knowledge, no previously
reported features of H1 subtypes anticipated these results. H1.0
is highly abundant in terminally differentiated cells, while somatic
H1 variants (H1.1-H1.5) are present in dividing cells with differing
abundance depending on cell type. Interestingly, no human cell
line lacking expression of H1.2 or H1.4 has been found to date,
supporting the important role of these two isoforms [45,46]. These
reports show that all cell types tested express H1.2 and H1.4 at a
high level, each accounting for at least 20% of the cellular H1
content. In contrast, cell types can be found where some of the
other H1 subtypes are not detectable or at very low levels (#5% of
total H1). This is in agreement with our estimations of the H1
content in the five cell lines used in this report. Analysis of the H1
variants pattern in T47D cells combining gel electrophoresis and
immunoblotting (Figure S1 and data not shown) indicated that the
relative contribution of subtypes to the total H1 content was
approximately as follows: 9% for H1.0, 23% for H1.2, 13% for
H1.3, 24% for H1.4 and 31% for H1.5.On the other hand, the
amount of H1.5 was low in HeLa and 293T, H1.3 was
undetectable in HeLa, and H1.0 almost inexistent in MCF10A
(Figure 4).
Histone H1.4 depletion had a strong impact on cell survival of
T47D cells. This cell line is functionally defective in p53 and
caspase-3, and consequently these cells do not undergo apoptosis
in response to stress or damage. Indeed, we have been unable to
detect signs of apoptotic death upon H1.4 depletion. Six days after
induction of H1.4 KD, few cells remained attached to the culture
Figure 9. Cell cycle gene alterations in H1.2 knock-down cells. (A) Complementation of altered expression of cell cycle-related genes in H1.2
knocked-down cells by stable expression of recombinant HA-tagged, shRNA-resistant H1.2. Expression of the cell cycle genes indicated was measured
by RT-qPCR with specific oligonucelotides in parental H1.2 KD and H1.2sh/rH1.2HA cells treated or not with Dox for 6 days. GAPDH expression was
measured for normalization. Data is expressed as relative units specific gene/GAPDH. The values represent the mean and SD of a representative
experiment performed in triplicate. (B) Changes in the accumulation or phosphorylation of cell cycle-related proteins upon inhibition of H1.2.
Expression of the indicated proteins was measured by Western blot with specific antibodies in cells treated or not with Dox for 6 days. H1.2 knocked-
down cells were compared to parental T47D or control cells. Tubulin antibody was used as loading control. (C) CDK2 activity in H1.2 depleted cells.
CDK2 was immunoprecipitated with the specific antibody from cellular extracts of Dox-treated or untreated cells (H1.2 KD or control) and incubated
with histone H1 and c-ATP. Products were resolved in SDS-PAGE and detected by autoradiography. Immunoprecipitated material was measured by
immunoblotting with the anti CDK2 antibody.
doi:10.1371/journal.pgen.1000227.g009
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flask, and these cells presented a necrotic phenotype. When the
cell cycle profile was analyzed, very few cycling cells were detected
and FACS analysis identified the presence of cells in the subG1
window. Gene expression profiles showed the alteration in
expression of a considerable number of cell cycle related genes.
Although our data suggests that H1.4 is essential for T47D cell
growth, at this point it cannot be discarded a more complicated
explanation as a consequence of indirect effects of H1.4 depletion,
such as the resulting increased expression of H1.0.
Depletion of H1.2 in T47D cells caused G1 arrest and,
consequently, slow proliferation. This effect is specific to H1.2
depletion, as it did not occur in KD cells for the other variants and
it was complemented solely by the reintroduction of recombinant,
shRNA-resistant H1.2.
The effects of H1.2 or H1.4 depletion are not unique to the
T47D cell line, but are also observed in MCF7 and MCF10A cells,
respectively. Noteworthy, H1.2 depletion did not cause G1 arrest
in MCF7 but rather an apoptotic phenotype. Differences in
genetic background between cell lines may explain different
outcomes for the same stress. For instance, unlike T47D, MCF7 is
p53-positive and prone to apoptosis. Cell lines from other origins
did not exhibit a cell cycle phenotype in response to H1.2 KD.
This is perplexing as H1.2 accounts for almost 50% of the total H1
content in HeLa (Figure 4A and [46]), and is also highly abundant
in 293T. This suggests that the effect of H1 depletion is cell type
specific and unlinked to the relative amount of each variant in the
cell, nor correlates with the efficiency of depletion achieved by
RNA interference.
Tumor cells undergo uncontrolled proliferation, arising from
the ability to bypass the quiescent state characteristic of most
normal cells from adult tissues [41]. H1.2 depletion blocks the
proliferative potential of breast cancer cells and therefore
unraveling the underlying mechanism could provide insights into
how normal cells become tumorigenic.
Effect of H1.2 Depletion on Nucleosome Spacing and
Chromatin Organization
Triple null H1-2-H1.3-h1.5 mouse embryonic stem (ES) cells
present a 15 base pair reduction in the bulk chromatin NRL [12].
H1.2 depletion of breast cancer cells altered chromatin organiza-
tion, measured as nucleosome spacing after controlled MNase
digestion of nuclei. NRL was decreased by about 11 bp upon H1.2
depletion, and the effect was specific to this subtype and
complemented by recombinant H1.2 expression. This was
unexpected as a reduction of NRL has been reported only after
a significant (50% or higher) decrease in H1 content [12]. We
estimated that H1.2 accounts for only about 20–25% of the total
H1 content in T47D cells and depletion by shRNA was not
complete. In our experiments, depletion of other H1 subtypes
accounting for a similar or higher percentage of total H1 (H1.4
and H1.5) had no effect on chromatin structure, indicating that
H1.2 may play a specific role in chromatin organization or
nucleosome spacing.
Triple KO mouse ES cells proliferate at the same rate as WT
ES cells and also exhibit a decrease in the levels of some core
histone modifications as well as in CpG methylation within the
regulatory regions of certain genes [12]. So far, we have not
detected changes in global histone modifications nor in DNA
methylation upon H1.2 depletion (data not shown). Using a
microarray platform to measure methylation of CpG loci in 807
genes (including cell cycle control, apoptosis, chromosome X-
linked, and imprinted genes), we have not observed significant
changes in H1.2 KD cells treated or not with Dox for 6 days (M.
Sancho, A. Ferna´ndez, M. Beato, M. Esteller, A. Jordan;
unpublished results). Epigenetic changes to compensate for H1
depletion in ES cells may require longer times and may allow cell
survival under selective pressure, whereas rapid induction of H1.2
shRNA does not allow for compensation effects to appear before
cell progression is compromised.
We have not yet been able to establish a causative relation
between the reduced nucleosome spacing and the cell cycle arrest
in G1 phase observed upon H1.2 depletion in T47D. Alterations
of chromatin organization could affect progression of the
replication fork, or could expose to damage regions of DNA
leading to a damage response. It has been recently reported that
H1-depleted cells (triple KO ES cells) are hyper resistant to DNA
damage and present hypersensitive checkpoints (G2/M arrest
induced at lower doses), explained by increased signaling
generated at each DNA break [47]. If so, upon H1.2 depletion
we would expect S or G2/M arrest in response to damaging agents
such as HU or MMS, respectively. But we have clearly shown that
G1-arrest is dominant with regard to arrest caused by such
compounds.
H1 depletion could also have an effect on the formation and
stability of mitotic chromosomes. In the absence of H1,
chromosomes assembled and replicated in Xenopus egg extracts
failed to compact properly, leading to segregation anomalies [48].
In triple KO mouse ES cells, no abnormalities in mitosis and
normal division time were detected [12]. Nonetheless, the decrease
in H1 leads to a general increase in telomere length [47]. It
remains to be explored if selective H1.2 depletion leads to
chromosomal abnormalities.
Changes in Expression of Cell Cycle Genes
Chromatin missorganization could also cause changes in the
expression of sensitive promoters that may include genes relevant
for cell proliferation. Alternatively, H1.2 may be a specific
regulator of some particular promoters. It has been reported
before that H1.5 interacts with transcription factor MSX1 and
both are recruited to specific promoters to control myogenesis
[19]. On the other hand, H1.2 has been found to be part of a
complex that represses p53-mediated transcription in HeLa cells
[24]. With this idea in mind, we have explored what changes in
gene expression profiles occur upon depletion of different H1
subtypes. Less than 10% of the genes present in a customized
microarray (and almost 2% on a genome-wide array) were altered
in its expression upon H1.2 knock-down and most of them were
repressed. This behavior has been reported before [14–16] and is
indicative of H1 acting as an active regulator of gene expression,
not solely a repressor due to its chromatin compaction properties.
Repressed genes included a relevant proportion of cell cycle-
related genes. We reject the possibility that this is due to different
proportion of cells in the different cell cycle phases upon exposure
to the shRNA, as all cell populations were equivalently arrested in
G1 due to serum-starvation for the gene expression experiments.
Rather we found an effect of H1.2 deprivation on a subset of cell
cycle related genes, some of which are in line with the G1 arrest
phenotype and may be the link to the cell proliferation defect.
Replicative or premature, stress-induced senescence is charac-
terized by maintenance of cells in a growth-arrest state
(comparable to G1 arrest), by forming heterochromatin at
proliferation-promoting gene loci (E2F target genes). It has
recently been suggested that alteration in histone H1 metabolism
may be involved in a cellular senescence-inducing mechanism
[49]. Senescent fibroblasts show reduced levels of chromatin-
bound endogenous H1. That report did not clarify whether
histone H1 loss plays a causative role in senescence induction or is
only an effect of the process, as RNA interference of H1 was
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unsuccessful. Our data suggests that specific H1 subtype loss from
chromatin may cause by itself this phenotype in T47D cells,
indicating that H1 loss may be a messenger between senescence-
inducing signals and the molecular response leading to growth
arrest.
G1 progression and entry into S phase depends on the activity
of two cell cycle kinase-complexes, CDK4/6-cyclin D and CDK2-
cyclin E, that work in concert to relieve inhibition of a dynamic
transcription complex that contains retinoblastoma (Rb) protein
and E2F. Phosphorylation of Rb by CDK4/6 and CDK2
dissociates the Rb-HDAC repressor complex, permitting tran-
scription of key S-phase-promoting genes, including some required
for DNA replication [40]. Downstream genes controlled by E2F,
such as CDC2 and PCNA are repressed in the absence of H1.2.
CDKs activity is regulated by members of the INK4 (p15, p16,
p18, p19) or KIP/CIP (p27, p21) families of cyclin dependent
kinase inhibitors induced by different agents or growth conditions
promoting cell cycle arrest, differentiation or apoptosis. In H1.2
knock-down cells (+Dox), Rb remains unphosphorylated when
compared with 2Dox cells, indicating that the cause of G1 arrest
is upstream Rb phosphorylation by CDKs. p16INK4A, p27Kip1 and
p53-inducible p21Cip1 could be candidates to explain low Rb
phosphorylation, but we have not appreciated any difference in
the level of either inhibitor in H1.2 KD cells, despite the fact that
the CDKN1A (p21Cip1) gene is induced upon H1.2 depletion.
Involvement of other inhibitors of the INK4 family needs to be
tested. Cyclin D1 and CDK4 levels also remain unaltered. On the
contrary, CDK2 and CDC2 levels are reduced in H1.2 KD cells.
The CDC2 (CDK1)-Cyclin E pair has been involved recently in
G1/S transition and could substitute CDK2, and so it could also
account for Rb phosphorylation [50,51]. Reduced levels of these
two proteins may account for cell cycle arrest by itself, or in
combination with additional yet unrecognized factors. Among the
repressed genes in H1.2 KD cells, there are genes involved in
initiation of replication such as those encoding for CDC6,
CDC45L, PCNA and several MCM proteins. Down-regulation
of these factors could prevent entry into S phase and,
consequently, cells would remain in G1. Another set of repressed
genes encode for proteins involved in G2/M transition, such as
CDC2, and mitosis progression, such as MAD2L1, CDC20 and
CDC23, cyclin B, aurora kinase B. Their repression does not
explain the G1 arrest, but may be part of a gene network co-
regulated by H1.2 depletion.
It is difficult to unequivocally assign a gene or group of genes as
direct targets of the H1.2 depletion or as responsible of the G1
arrest phenotype. The first would require investigation into the
participation of this particular histone subtype in the promoter
activation process of candidate genes by chromatin immunopre-
cipitation, but H1 subtype specific antibodies generated have been
useless to date for this application. The second would require
testing the effect of interfering with each cell cycle-related
candidate gene. Probably, simultaneous, incomplete silencing of
several genes would be needed to recapitulate the G1 arrest
observed here [52]. Our data and data published elsewhere are
indicative that depletion of cell cycle regulatory proteins such as
CDC2, CDK2, CDC20, MCMs or PCNA is deleterious for cell
cycle progression [53–55].
H1 Variants Play Specific and Redundant Roles in Gene
Expression Regulation
Global gene expression profiling combining inducible H1 variant
depletion and genome-wide microarrays has allowed us to define
the subsets of genes regulated directly or indirectly by each variant.
The overall number of regulated genes and the proportion of genes
up- or down-regulated differ between H1 isoforms. Depletion of the
different H1 variants caused an alteration in the expression of a
limited number of genes, different in each H1 variant KD. Most of
the genes (79%) are affected by a single H1 variant, supporting the
theory that H1 isoforms play specific roles in gene expression.
Nonetheless, a proportion of genes are altered by more than one H1
variant, suggesting that redundant roles for H1 variants in gene
expression regulation may also exist. 13% of genes were altered in
two variant KDs, and only 1% of genes were affected (down-
regulated) in each of the five KDs. This is in agreement with a recent
report showing that overexpression of mouse H10 and H1c (human
H1.0 and H1.2 orthologs) altered a limited number of variant-
specific genes, as well as a smaller number of commonly regulated
genes [16]. In that case, too, genes were either up- or down-
regulated upon H1 overproduction, with a stronger predominance
of up-regulated genes in the H1c-overexpressing cells and a major
number of down-regulated genes in the H10 cell line. Similarly, we
have obtained a higher ratio down- to up-regulated genes in the
H1.2 KD (ratio DW:UP = 2.7) than in the H1.0 KD (ratio = 1.9).
This supports the theory that H1.0 is a stronger repressor of
transcription and H1.2 may play a role as transcription activator or
facilitator. Nonetheless, following with this argument, H1.4 and
H1.5 would be even more repressive (ratio = 1.4 and 1, respectively).
This, actually, fits with previous description of histone H1 variant
distribution and compaction capability. It has been proposed that
mouse H1.0, H1.4 and H1.5 promote formation of compact
chromatin and are enriched in more compact chromatin, while
H1.2 condenses chromatin less effectively and is enriched in less
condensed chromatin regions [8,56].
Our analysis has also shown that H1.3, and especially H1.2 and
H1.4, are the most specific variants in controlling gene expression,
with a higher number of uniquely regulated genes. This might be
related to the essentiality of H1.2 and H1.4 in breast cancer cells
reported here, and with the fact that no cell types lacking any of
the two variants have been found to date. These two isoforms may
play more specific roles, while the other variants may be more
redundant. This is still speculation and to proof it would need to
cross the different H1 variant knock-downs with all the vectors for
ectopic expression of HA-tagged recombinant isoforms.
Considering that histone H1 is a global chromatin component,
our and previous reports studying global gene expression changes
in response to H1 depletion [12–15], show that H1 affects
expression of a surprisingly reduced number of genes. Here,
approximately 6% of the genes present in the 22K-gene
microarray show altered expression (.1.4-fold) upon inhibition
of some of the five H1 variants tested. Nevertheless, not all the
genes present in the microarray platform are expressed in this
breast cancer cell line growing under the conditions used, i.e. G1
arrest caused by serum starvation. Only about 36% of the genes
were expressed above background (data not shown). This increases
the proportion of genes being affected by depletion of some H1
variant in up to 16% of expressed genes (6.6% up- and 10% down-
regulated by H1 depletion). This is already a considerable number
of affected genes, larger than the 0.56% of expressed genes
affected (.2-fold) in mouse triple H1 knock-out embryonic
fibroblasts published elsewhere [12]. If we also consider a .2-
fold variation in gene expression for the analysis of data, 2% of
expressed genes are still affected upon depletion of some H1
variant. The striking difference between the two studies —with all
due caution with regard to differences in the data analysis
procedure applied— might be due to the inducible nature of the
knock-down strategy used here. Along a small number of cell
divisions, cells are encountered with a reduced level of a particular
isoform. In the triple mutant, cells have been selected for survival
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and have adapted to the new situation, allowing for the resetting of
a hypothetical basal gene expression profile required for the
maintenance and progression of cells.
In conclusion, our approach of inducible depletion of individual
H1 variants using RNA interference technology has revealed that
H1 subtypes are not fully redundant but may have differentiated
functions in some of their nuclear roles, including nucleosome
spacing and gene expression control, impacting on important
cellular events such as proliferation.
Supporting Information
Figure S1 Characterization of human histone H1 variant-
specific antibodies and analysis of the H1 variants pattern in
T47D cells.
Found at: doi:10.1371/journal.pgen.1000227.s001 (0.15 MB PDF)
Figure S2 Rescue of the deleterious effect of H1.4 shRNA by
transient expression of recombinant shRNA-resistant H1.4.
Found at: doi:10.1371/journal.pgen.1000227.s002 (0.14 MB PDF)
Figure S3 Incorporation of recombinant HA-tagged H1 iso-
forms into chromatin.
Found at: doi:10.1371/journal.pgen.1000227.s003 (0.05 MB PDF)
Figure S4 Cell cycle gene alterations in H1.2 knock-down cells.
Found at: doi:10.1371/journal.pgen.1000227.s004 (0.03 MB PDF)
Table S1 Cell cycle profile after PI staining of H1 variant KD
cell lines grown in the presence or absence of Dox.
Found at: doi:10.1371/journal.pgen.1000227.s005 (0.01 MB PDF)
Table S2 Summary of gene expression altered upon H1 variant
depletion.
Found at: doi:10.1371/journal.pgen.1000227.s006 (0.01 MB PDF)
Table S3 Number of genes regulated uniquely or coincidently
between different isoforms.
Found at: doi:10.1371/journal.pgen.1000227.s007 (0.01 MB PDF)
Table S4 Effect of H1 variant inhibition on the expression of 84
genes key to cell cycle regulation.
Found at: doi:10.1371/journal.pgen.1000227.s008 (0.02 MB PDF)
Table S5 Nomenclature of genes shown in Figure 6.
Found at: doi:10.1371/journal.pgen.1000227.s009 (0.02 MB PDF)
Table S6 Nomenclature of genes included in the RT Profiler
PCR Array.
Found at: doi:10.1371/journal.pgen.1000227.s010 (0.02 MB PDF)
Text S1 Suppplementary figure legends and Materials &
Methods.
Found at: doi:10.1371/journal.pgen.1000227.s011 (0.12 MB PDF)
Acknowledgments
We wish to thank Didier Trono and Maciej Wiznerowicz (Univ. of
Geneva, Switzerland), for providing the inducible shRNA expression
system; Agustı´n Ferna´ndez and Manel Esteller (CNIO), for analysis of
DNA methylation; Nicole Happel and Detlef Doenecke (Univ. Go¨ttingen,
Germany), for recombinant H1 variants; Danny Reinberg (NYU Medical
School), for the pCDNA4-HA vector; B. Min˜ana, X. Pastor and L. Sumoy
(CRG), for the microarray experiments and data submission to GEO; J.
Clausell and M. Edel (CRG), for helpful discussion; F. Mateo and O. Bachs
(IDIBABS-UB), for help with CDK activity assays.
Author Contributions
Conceived and designed the experiments: MB AJ. Performed the
experiments: MS ED. Analyzed the data: MS AJ. Contributed reagents/
materials/analysis tools: MS. Wrote the paper: AJ.
References
1. Brown DT (2003) Histone H1 and the dynamic regulation of chromatin
function. Biochem Cell Biol 81(3): 221–227.
2. Bustin M, Catez F, Lim JH (2005) The dynamics of histone H1 function in
chromatin. Mol Cell 17(5): 617–620.
3. Woodcock CL, Skoultchi AI, Fan Y (2006) Role of linker histone in chromatin
structure and function: H1 stoichiometry and nucleosome repeat length.
Chromosome Res 14(1): 17–25.
4. Garcia BA, Busby SA, Barber CM, Shabanowitz J, Allis CD, et al. (2004)
Characterization of phosphorylation sites on histone H1 isoforms by tandem
mass spectrometry. J Proteome Res 3(6): 1219–1227.
5. Wisniewski JR, Zougman A, Kruger S, Mann M (2007) Mass spectrometric
mapping of linker histone H1 variants reveals multiple acetylations, methyla-
tions, and phosphorylation as well as differences between cell culture and tissue.
Mol Cell Proteomics 6(1): 72–87.
6. Talasz H, Helliger W, Puschendorf B, Lindner H (1996) In vivo phosphorylation
of histone H1 variants during the cell cycle. Biochemistry 35(6): 1761–1767.
7. Doenecke D, Albig W, Bode C, Drabent B, Franke K, et al. (1997) Histones:
genetic diversity and tissue-specific gene expression. Histochem Cell Biol 107(1):
1–10.
8. Parseghian MH, Hamkalo BA (2001) A compendium of the histone H1 family of
somatic subtypes: an elusive cast of characters and their characteristics. Biochem
Cell Biol 79(3): 289–304.
9. Happel N, Schulze E, Doenecke D (2005) Characterisation of human histone
H1x. Biol Chem 386(6): 541–551.
10. Izzo A, Kamieniarz K, Schneider R (2008) The histone H1 family: specific
members, specific functions? Biol Chem 389(4): 333–43.
11. Hill DA (2001) Influence of linker histone H1 on chromatin remodeling.
Biochem Cell Biol 79(3): 317–324.
12. Fan Y, Nikitina T, Zhao J, Fleury TJ, Bhattacharyya R, et al. (2005) Histone H1
depletion in mammals alters global chromatin structure but causes specific
changes in gene regulation. Cell 123(7): 1199–1212.
13. Shen X, Gorovsky MA (1996) Linker histone H1 regulates specific gene
expression but not global transcription in vivo. Cell 86(3): 475–483.
14. Lin Q, Inselman A, Han X, Xu H, Zhang W, et al. (2004) Reductions in linker
histone levels are tolerated in developing spermatocytes but cause changes in
specific gene expression. J Biol Chem 279(22): 23525–23535.
15. Hellauer K, Sirard E, Turcotte B (2001) Decreased expression of specific genes
in yeast cells lacking histone H1. J Biol Chem 276(17): 13587–13592.
16. Bhan S, May W, Warren SL, Sittman DB (2008) Global gene expression analysis
reveals specific and redundant roles for H1 variants, H1c and H1(0), in gene
expression regulation. Gene 414(1–2): 10–18.
17. Sera T, Wolffe AP (1998) Role of histone H1 as an architectural determinant of
chromatin structure and as a specific repressor of transcription on Xenopus
oocyte 5S rRNA genes. Mol Cell Biol 18(7): 3668–3680.
18. Gunjan A, Brown DT (1999) Overproduction of histone H1 variants in vivo
increases basal and induced activity of the mouse mammary tumor virus
promoter. Nucleic Acids Res 27(16): 3355–3363.
19. Lee H, Habas R, Abate-Shen C (2004) MSX1 cooperates with histone H1b for
inhibition of transcription and myogenesis. Science 304(5677): 1675–1678.
20. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, et al. (2004)
Human SirT1 interacts with histone H1 and promotes formation of facultative
heterochromatin. Mol Cell 16(1): 93–105.
21. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D (2004) Different EZH2-
containing complexes target methylation of histone H1 or nucleosomal histone
H3. Mol Cell 14(2): 183–193.
22. Daujat S, Zeissler U, Waldmann T, Happel N, Schneider R (2005) HP1 binds
specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27
phosphorylation blocks HP1 binding. J Biol Chem 280(45): 38090–38095.
23. Hale TK, Contreras A, Morrison AJ, Herrera RE (2006) Phosphorylation of the
linker histone H1 by CDK regulates its binding to HP1alpha. Mol Cell 22(5):
693–699.
24. Kim K, Choi J, Heo K, Kim H, Levens D, et al. (2008) Isolation and
characterization of a novel H1.2 complex that acts as a repressor of p53-
mediated transcription. J Biol Chem 283(14): 9113–9126.
25. Konishi A, Shimizu S, Hirota J, Takao T, Fan Y, et al. (2003) Involvement of
histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell 114(6):
673–688.
26. Barra JL, Rhounim L, Rossignol JL, Faugeron G (2000) Histone H1 is
dispensable for methylation-associated gene silencing in Ascobolus immersus
and essential for long life span. Mol Cell Biol 20(1): 61–69.
27. Wierzbicki AT, Jerzmanowski A (2005) Suppression of histone H1 genes in
Arabidopsis results in heritable developmental defects and stochastic changes in
DNA methylation. Genetics 169(2): 997–1008.
28. Jedrusik MA, Schulze E (2001) A single histone H1 isoform (H1.1) is essential for
chromatin silencing and germline development in Caenorhabditis elegans.
Development 128(7): 1069–1080.
Specificity of H1 Variants
PLoS Genetics | www.plosgenetics.org 16 October 2008 | Volume 4 | Issue 10 | e1000227
29. Fan Y, Sirotkin A, Russell RG, Ayala J, Skoultchi AI (2001) Individual somatic
H1 subtypes are dispensable for mouse development even in mice lacking the
H1(0) replacement subtype. Mol Cell Biol 21(23): 7933–7943.
30. Fan Y, Nikitina T, Morin-Kensicki EM, Zhao J, Magnuson TR, et al. (2003) H1
linker histones are essential for mouse development and affect nucleosome
spacing in vivo. Mol Cell Biol 23(13): 4559–4572.
31. Vicent GP, Melia MJ, Beato M (2002) Asymmetric binding of histone H1
stabilizes MMTV nucleosomes and the interaction of progesterone receptor with
the exposed HRE. J Mol Biol 324(3): 501–517.
32. Koop R, DiCroce L, Beato M (2003) Histone H1 enhances synergistic activation
of the MMTV promoter in chromatin. EMBO J 22(3): 588–599.
33. Truss M, Bartsch J, Schelbert A, Hache RJ, Beato M (1995) Hormone induces
binding of receptors and transcription factors to a rearranged nucleosome on the
MMTV promoter in vivo. EMBO J 14(8): 1737–1751.
34. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes:
lentivirus vector-mediated drug-inducible RNA interference. J Virol 77(16):
8957–8961.
35. Perez-Burgos L, Peters AH, Opravil S, Kauer M, Mechtler K, et al. (2004)
Generation and characterization of methyl-lysine histone antibodies. Methods
Enzymol 376: 234–254.
36. Subtil-Rodriguez A, Millan-Arino L, Quiles I, Ballare C, Beato M, et al. (2008)
Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2
promoter in breast cancer cells involves coordinated recruitment of STAT5A
and progesterone receptor to a distal enhancer and polymerase tracking. Mol
Cell Biol 28(11): 3830–3849.
37. Canela N, Orzaez M, Fucho R, Mateo F, Gutierrez R, et al. (2006)
Identification of an hexapeptide that binds to a surface pocket in cyclin A and
inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A. J
Biol Chem 281(47): 35942–35953.
38. Meyerson M, Harlow E (1994) Identification of G1 kinase activity for cdk6, a
novel cyclin D partner. Mol Cell Biol 14(3): 2077–2086.
39. Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina
microarray. Bioinformatics 24(13): 1547–1548.
40. Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and
emerging paradigms. Genes Dev 14(19): 2393–2409.
41. Malumbres M, Barbacid M (2001) To cycle or not to cycle: a critical decision in
cancer. Nat Rev Cancer 1(3): 222–231.
42. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of
G1-phase progression. Genes Dev 13(12): 1501–1512.
43. Brown DT (2001) Histone variants: are they functionally heterogeneous?
Genome Biol 2(7): REVIEWS0006.
44. Brown DT, Alexander BT, Sittman DB (1996) Differential effect of H1 variant
overexpression on cell cycle progression and gene expression. Nucleic Acids Res
24(3): 486–493.
45. Meergans T, Albig W, Doenecke D (1997) Varied expression patterns of human
H1 histone genes in different cell lines. DNA Cell Biol 16(9): 1041–1049.
46. Kratzmeier M, Albig W, Meergans T, Doenecke D (1999) Changes in the
protein pattern of H1 histones associated with apoptotic DNA fragmentation.
Biochem J 337 (Pt 2): 319–327.
47. Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, et al. (2007) Global
chromatin compaction limits the strength of the DNA damage response. J Cell
Biol 178(7): 1101–1108.
48. Maresca TJ, Freedman BS, Heald R (2005) Histone H1 is essential for mitotic
chromosome architecture and segregation in Xenopus laevis egg extracts. J Cell
Biol 169(6): 859–869.
49. Funayama R, Saito M, Tanobe H, Ishikawa F (2006) Loss of linker histone H1
in cellular senescence. J Cell Biol 175(6): 869–880.
50. Martin A, Odajima J, Hunt SL, Dubus P, Ortega S, et al. (2005) Cdk2 is
dispensable for cell cycle inhibition and tumor suppression mediated by
p27(Kip1) and p21(Cip1). Cancer Cell 7(6): 591–598.
51. Aleem E, Kiyokawa H, Kaldis P (2005) Cdc2-cyclin E complexes regulate the
G1/S phase transition. Nat Cell Biol 7(8): 831–836.
52. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, et al. (2007)
Transcripts targeted by the microRNA-16 family cooperatively regulate cell
cycle progression. Mol Cell Biol 27(6): 2240–2252.
53. Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, et al. (2008) Cancer
proliferation gene discovery through functional genomics. Science 319(5863):
620–624.
54. Silva JM, Marran K, Parker JS, Silva J, Golding M, et al. (2008) Profiling
essential genes in human mammary cells by multiplex RNAi screening. Science
319(5863): 617–620.
55. Kittler R, Pelletier L, Heninger AK, Slabicki M, Theis M, et al. (2007) Genome-
scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol
9(12): 1401–1412.
56. Lennox RW (1984) Differences in evolutionary stability among mammalian H1
subtypes. Implications for the roles of H1 subtypes in chromatin. J Biol Chem
259(1): 669–672.
Specificity of H1 Variants
PLoS Genetics | www.plosgenetics.org 17 October 2008 | Volume 4 | Issue 10 | e1000227
